Trial Profile
Gene expression in letrozole treated breast cancer
Status:
Active, no longer recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 28 Sep 2006
Price :
$35
*
At a glance
- Drugs Letrozole (Primary)
- Indications Breast cancer
- Focus Pharmacogenomic; Therapeutic Use
- 28 Sep 2006 New trial record.